Stocklytics Platform
Asset logo for symbol ZURA
Zura Bio Ltd.
ZURA56
$3.60arrow_drop_down17.69%-$0.77
Penny Stock
Asset logo for symbol ZURA
ZURA56

$3.60

arrow_drop_down17.69%

Performance History

Chart placeholder
Key Stats
Open$4.64
Prev. Close$4.72
EPS0.57
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$283.79M
LOWHIGH
Day Range4.42
4.90
52 Week Range2.00
7.10
Ratios
Revenue-
EBITDA Margin %-
EPS0.57

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Zura Bio Ltd. (ZURA)

Zura Bio Ltd. (ZURA) is a biotechnology company focused on the development of innovative treatments for neurological disorders. The company specializes in the discovery and development of small molecule therapeutics that target specific molecular pathways associated with these disorders. ZURA is committed to advancing the understanding of these diseases and translating that knowledge into effective therapeutic options for patients.
The stock price history of Zura Bio Ltd. (ZURA) reflects the company's progress and potential in the biotech industry. Over the past year, the stock has shown steady growth, with occasional fluctuations due to market conditions and investor sentiment. This consistent performance is a testament to the company's strong management team and promising drug pipeline.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Someit Sidhu M.D.
Headquarters
San Diego
Employees
0
Exchange
NASDAQ
add Zura Bio Ltd. to watchlist

Keep an eye on Zura Bio Ltd.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Zura Bio Ltd.'s (ZURA) price per share?

The current price per share for Zura Bio Ltd. (ZURA) is $3.6. The stock has seen a price change of -$0.77 recently, indicating a -17.69% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Zura Bio Ltd. (ZURA)?

For Zura Bio Ltd. (ZURA), the 52-week high is $7.1, which is 97.22% from the current price. The 52-week low is $2, the current price is 80% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Zura Bio Ltd. (ZURA) a growth stock?

Zura Bio Ltd. (ZURA) has shown an average price growth of -3.55% over the past three years. It has received a score of 47 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Zura Bio Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Zura Bio Ltd. (ZURA) stock price performance year to date (YTD)?

As of the latest data, Zura Bio Ltd. (ZURA) has a year-to-date price change of -17.24%. Over the past month, the stock has experienced a price change of -11.33%. Over the last three months, the change has been 10.77%. Over the past six months, the figure is -30.23%.
help

Is Zura Bio Ltd. (ZURA) a profitable company?

Zura Bio Ltd. (ZURA) has a net income of -$60.56M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$62.64M. Furthermore, the EBITDA is $0.
help

What is the market capitalization of Zura Bio Ltd. (ZURA)?

Zura Bio Ltd. (ZURA) has a market capitalization of $229.59M. The average daily trading volume is 3.79, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level